Genes & biomarkers

ESR1 variants

ESR1 · estrogen receptor

ER-positive pathology and an ESR1 variant are different pieces of information.

Sources checked · Introductory guide

On this page

What does this result mean?

ESR1 encodes the estrogen receptor. ER positivity describes receptor protein; an ESR1 variant describes a DNA change. One result cannot substitute for the other.[1]

How does it connect to treatment?

In the US, elacestrant is used in selected postmenopausal women and adult men with ESR1-mutated, ER-positive, HER2-negative advanced breast cancer after endocrine progression. Check individual eligibility and local access.[2]

What should I check in my report?

Review the test date, exact ESR1 variant and previous endocrine drugs. ER positivity alone is not an ESR1 mutation result.

Questions for your care team

  • Would ESR1 testing help before changing my current treatment?
  • Which treatments or trials fit my cancer type, stage and previous treatment?

Sources and scope

Source documents are in English.

Entries summarize and translate linked official public sources. The source-check date records when those sources were checked; it does not indicate a clinician’s review.

  1. NCI · Elacestrant Dihydrochloride (opens in a new tab)
  2. FDA · ORSERDU prescribing information (opens in a new tab)

General information based on official public sources. This is not a complete list of uses or side effects. Individual treatment decisions require your care team and current source documents. US-source uses do not establish local approval or reimbursement.

Related entries

ESR1 variants | Cancer Encyclopedia | My Chemo Diary